Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Real-time PCR detection of Phaeomoniella chlamydospora and Phaeoacremonium aleophilum

  • Martín, María Teresa
  • Cobos Román, Rebeca
  • Martín, Laura
  • López Enríquez, Lorena
[EN] Phaeomoniella chlamydospora and Phaeoacremonium aleophilum are the two main fungal causal agents of Petri disease and esca. Both diseases cause significant economic losses to viticulturalists. Since no curative control measures are known, proactive defensive measures must be taken. An important aspect of current research is the development of sensitive and time-saving protocols for the detection and identification of these pathogens. Real-time PCR based on the amplification of specific sequences is now being used for the identification and quantification of many infective agents. The present work reports real-time PCR protocols for identification of P. chlamydospora and P. aleophilum. Specificity was demonstrated against purified DNA from 60 P. chlamydospora isolates or 61 P. aleophilum isolates, and no amplification was obtained with 54 nontarget DNAs. The limits of detection (i.e., DNA detectable in 95% of reactions) were around 100 fg for P. chlamydospora and 50 fg for P. aleophilum. Detection was specific and sensitive for P. chlamydospora and P. aleophilum. Spores of P. chlamydospora and P. aleophilum were detected without the need for DNA purification. The established protocols detected these fungi in wood samples after DNA purification. P. chlamydospora was detectable without DNA purification and isolation in 67% of reactions. The detection of these pathogens in wood samples has great potential for use in pathogen-free certification schemes, SI, This research was partly funded by Project INIA RTA04-127. Rebeca Cobos and Laura Martín were supported by an Itacyl-PhD grant and project PTA-2003-01-01001, respectively. Maria Teresa Martín was supported by Contratos Doctores Sistema INIA-CCAA (37, DR07-0161). Marta Hernández provided helpful insight.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mesenchymal stem cells regulate airway contractile tissue remodeling in murine experimental asthma

  • Mariñas-Pardo, Luis
  • Mirones, Isabel
  • Amor-Carro, Oscar|||0009-0009-0696-5739
  • Fraga-Iriso, Rebeca
  • Lema-Costa, Beatriz
  • Cubillo, Isabel María
  • Rodríguez Milla, Miguel Ángel
  • García-Castro, Javier
  • Ramos-Barbón, David|||0000-0002-9615-6557
Background Mesenchymal stem cells may offer therapeutic potential for asthma due to their immunomodulatory properties and host tolerability, yet prior evidence suggests that bloodborne progenitor cells may participate in airway remodeling. Here, we tested whether mesenchymal stem cells administered as anti-inflammatory therapy may favor airway remodeling and therefore be detrimental. Methods Adipose tissue-derived mesenchymal stem cells were retrovirally transduced to express green fluorescent protein and intravenously injected into mice with established experimental asthma induced by repeat intranasal house dust mite extract. Controls were house dust mite-instilled animals receiving intravenous vehicle or phosphate-buffered saline-instilled animals receiving mesenchymal stem cells. Data on lung function, airway inflammation, and remodeling were collected at 72 h after injection or after 2 weeks of additional intranasal challenge. Results The mesenchymal stem cells homed to the lungs and rapidly downregulated airway inflammation in association with raised T-helper-1 lung cytokines, but such effect declined under sustained allergen challenge despite a persistent presence of mesenchymal stem cells. Conversely, airway hyperresponsiveness and contractile tissue underwent a late reduction regardless of continuous pathogenic stimuli and inflammatory rebound. Tracking of green fluorescent protein did not show mesenchymal stem cell integration or differentiation in airway wall tissues. Conclusions Therapeutic mesenchymal stem cell infusion in murine experimental asthma is free of unwanted pro-remodeling effects and ameliorates airway hyper-responsiveness and contractile tissue remodeling. These outcomes support furthering the development of mesenchymal stem cell-based asthma therapies, although caution and solid preclinical data building are warranted. © 2014 The Authors. Allergy published by John Wiley & Sons Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

RET Fusion Testing in Patients With NSCLC, The RETING Study

  • Conde, Esther
  • Hernandez, Susana
  • Rodriguez Carrillo, Jose Luis
  • Martinez, Rebeca
  • Alonso, Marta
  • Curto, Daniel
  • Jimenez, Beatriz
  • Caminoa, Alejandra
  • Benito, Amparo
  • Garrido, Pilar|||0000-0002-5899-6125
  • Clavé, Sergi|||0000-0002-9435-8454
  • Arriola, Edurne|||0000-0001-8960-7519
  • Esteban Rodríguez, Isabel|||0000-0003-1576-7215
  • Castro, Javier de|||0000-0002-3622-6306
  • Sansano, Irene|||0000-0003-0188-5210
  • Felip, Enriqueta|||0000-0002-7620-0098
  • Rojo, Federico|||0000-0001-9989-0290
  • Dómine Gómez, Manuel|||0000-0003-1634-9832
  • Abdulkader, Ihab
  • Garcia-Gonzalez, Jorge
  • Teixidó, Cristina|||0000-0002-7226-6567
  • Reguart, Noemi|||0000-0001-8190-499X
  • Compañ, Desamparados
  • Insa, Amelia|||0000-0002-3438-6170
  • Mancheño, Nuria
  • Palanca, Sarai
  • Juan, Óscar|||0000-0002-7772-9030
  • Baixeras, Nuria|||0000-0001-6127-0475
  • Nadal, Ernest|||0000-0002-9674-5554
  • Cebollero, Maria
  • Calles, Antonio
  • Martin, Paloma
  • Salas, Clara
  • Provencio Pulla, Mariano|||0000-0001-6315-7919
  • Aranda, Ignacio
  • Massuti, Bartomeu|||0000-0002-6247-4493
  • López Vilaró, Laura|||0000-0002-5428-8017
  • Majem Tarruella, Margarita|||0000-0002-9919-7485
  • Paz-Ares, Luis|||0000-0002-3327-3246
  • Lopez-Rios, Fernando
RET inhibitors with impressive overall response rates are now available for patients with NSCLC, yet the identification of RET fusions remains a difficult challenge. Most guidelines encourage the upfront use of next-generation sequencing (NGS), or alternatively, fluorescence in situ hybridization (FISH) or reverse transcriptase-polymerase chain reaction (RT-PCR) when NGS is not possible or available. Taken together, the suboptimal performance of single-analyte assays to detect RET fusions, although consistent with the notion of encouraging universal NGS, is currently widening some of the clinical practice gaps in the implementation of predictive biomarkers in patients with advanced NSCLC. This situation prompted us to evaluate several RET assays in a large multicenter cohort of RET fusion-positive NSCLC (n = 38) to obtain real-world data. In addition to RNA-based NGS (the criterion standard method), all positive specimens underwent break-apart RET FISH with two different assays and were also tested by an RT-PCR assay. The most common RET partners were KIF5B (78.9%), followed by CCDC6 (15.8%). The two RET NGS-positive but FISH-negative samples contained a KIF5B(15)-RET(12) fusion. The three RET fusions not identified with RT-PCR were AKAP13(35)-RET(12), KIF5B(24)-RET(9) and KIF5B(24)-RET(11). All three false-negative RT-PCR cases were FISH-positive, exhibited a typical break-apart pattern, and contained a very high number of positive tumor cells with both FISH assays. Signet ring cells, psammoma bodies, and pleomorphic features were frequently observed (in 34.2%, 39.5%, and 39.5% of tumors, respectively). In-depth knowledge of the advantages and disadvantages of the different RET testing methodologies could help clinical and molecular tumor boards implement and maintain sensible algorithms for the rapid and effective detection of RET fusions in patients with NSCLC. The likelihood of RET false-negative results with both FISH and RT-PCR reinforces the need for upfront NGS in patients with NSCLC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Emotional intelligence, a comparison between patients after first episode mania and those suffering from chronic bipolar disorder type I

  • Varo, Cristina|||0000-0002-8859-3052
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Sparacino, Giulio
  • Jiménez, Esther
  • Solé, Brisa|||0000-0003-1673-8248
  • Bonnin, Caterina del Mar|||0000-0002-1197-1596
  • Montejo, Laura|||0000-0003-4407-9454
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Torrent, Carla|||0000-0003-0335-582X
  • Salagre, Estela|||0000-0001-6352-5179
  • Benabarre, Antoni|||0000-0001-8814-2246
  • Salgado-Pineda, Pilar|||0000-0001-7720-0885
  • Montoro Salvatierra, Irene
  • Sáiz, Pilar A.|||0000-0002-5705-4523
  • García-Portilla, María Paz|||0000-0003-3643-1622
  • Sánchez Gistau, Vanessa|||0000-0002-8635-7144
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Pacchiarotti, Isabella|||0000-0002-7822-0367
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Undurraga, Juan|||0000-0001-6958-2369
  • Reinares, María|||0000-0001-8859-4453
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Vieta, Eduard|||0000-0002-0548-0053
  • Verdolini, Norma|||0000-0001-9488-2881
Deficits in emotional intelligence (EI) were detected in patients with bipolar disorder (BD), but little is known about whether these deficits are already present in patients after presenting a first episode mania (FEM). We sought (i) to compare EI in patients after a FEM, chronic BD and healthy controls (HC); (ii) to examine the effect exerted on EI by socio-demographic, clinical and neurocognitive variables in FEM patients. The Emotional Intelligence Quotient (EIQ) was calculated with the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT). Performance on MSCEIT was compared among the three groups using generalized linear models. In patients after a FEM, the influence of socio-demographic, clinical and neurocognitive variables on the EIQ was examined using a linear regression model. In total, 184 subjects were included (FEM n = 48, euthymic chronic BD type I n = 75, HC n = 61). BD patients performed significantly worse than HC on the EIQ [mean difference (MD) = 10.09, standard error ( = 3.14, p = 0.004] and on the understanding emotions branch (MD = 7.46, = 2.53, p = 0.010). FEM patients did not differ from HC and BD on other measures of MSCEIT. In patients after a FEM, EIQ was positively associated with female sex (β = -0.293, p = 0.034) and verbal memory performance (β = 0.374, p = 0.008). FEM patients performed worse than HC but better than BD on few neurocognitive domains. Patients after a FEM showed preserved EI, while patients in later stages of BD presented lower EIQ, suggesting that impairments in EI might result from the burden of disease and neurocognitive decline, associated with the chronicity of the illness.
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Fermionic light in common optical media

  • Novoa Fernández, David
  • Michinel Álvarez, Humberto Javier
  • Tommasini , Daniele
Recent experiments have proved that the response to short laser pulses of common optical media, such as air or oxygen, can be described by focusing Kerr and higher order nonlinearities of alternating signs. Such media support the propagation of steady solitary waves. We argue by both numerical and analytical computations that the low-power fundamental bright solitons satisfy an equation of state which is similar to that of a degenerate gas of fermions at zero temperature. Considering, in particular, the propagation in both O2 and air, we also find that the high-power solutions behave like droplets of ordinary liquids. We then show how a grid of the fermionic light bubbles can be generated and forced to merge in a liquid droplet. This leads us to propose a set of experiments aimed at the production of both the fermionic and liquid phases of light, and at the demonstration of the transition from the former to the latter., Ministerio de Ciencia e Innovación | Ref. FIS2008-01001
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Light by light diffraction in vacuum

  • Tommasini , Daniele
  • Michinel Álvarez, Humberto Javier
We show that a laser beam can be diffracted by a more concentrated light pulse due to quantum vacuum effects. We compute analytically the intensity pattern in a realistic experimental configuration, and discuss how it can be used to measure the parameters describing photon-photon scattering in vacuum. In particular, we show that the quantum electrodynamics prediction can be detected in a single-shot experiment at future 100-PW lasers such as ELI or HIPER. On the other hand, if carried out at one of the present high-power facilities, such as OMEGA EP, this proposal can lead either to the discovery of nonstandard physics or to substantial improvement in the current limits by PVLAS collaboration on the photon-photon cross section at optical wavelengths. This example of manipulation of light by light is simpler to realize and more sensitive than existing, alternative proposals, and can also be used to test Born-Infeld theory or to search for axionlike or minicharged particles., Ministerio de Ciencia e Innovación | Ref. FIS2008-01001, Universidade de Vigo
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

  • Conde, E.
  • Hernandez, S.
  • Martinez, R.
  • Angulo, B.
  • De Castro, J.
  • Collazo-Lorduy, A.
  • Jimenez, B.
  • Muriel, A.
  • Mate, J.L.
  • Moran, T.
  • Aranda, I.
  • Massuti, B.
  • Rojo, F.
  • Domine, M.
  • Sansano, I.
  • Garcia, F.
  • Felip, E.
  • Mancheño, N.
  • Juan, O.
  • Sanz, J.
  • Gonzalez-Larriba, J.L.
  • Atienza-Cuevas, L.
  • Arriola-Arellano, E.
  • Abdulkader, I.
  • Garcia-Gonzalez, J.
  • Camacho, C.
  • Rodriguez-Abreu, D.
  • Teixido, C.
  • Reguart, N.
  • Gonzalez-Piñeiro, A.
  • Lazaro-Quintela, M.
  • Lozano, M.D.
  • Gurpide, A.
  • Gomez-Roman, J.
  • Lopez-Brea, M.
  • Pijuan, L.
  • Salido, M.
  • Arriola, E.
  • Company, A.
  • Insa, A.
  • Esteban-Rodriguez, I.
  • Saiz, M.
  • Azkona, E.
  • Alvarez, R.
  • Artal, A.
  • Plaza, M.L.
  • Aguiar, D.
  • Enguita, A.B.
  • Benito, A.
  • Paz-Ares, L.
  • Garrido, P.
  • Lopez-Rios, F.
Introduction: The ROS1 gene rearrangement has become an important biomarker in NSCLC. The College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology testing guidelines support the use of ROS1 immunohistochemistry (IHC) as a screening test, followed by confirmation with fluorescence in situ hybridization (FISH) or a molecular test in all positive results. We have evaluated a novel anti-ROS1 IHC antibody (SP384) in a large multicenter series to obtain real-world data. Methods: A total of 43 ROS1 FISH–positive and 193 ROS1 FISH–negative NSCLC samples were studied. All specimens were screened by using two antibodies (clone D4D6 from Cell Signaling Technology and clone SP384 from Ventana Medical Systems), and the different interpretation criteria were compared with break-apart FISH (Vysis). FISH-positive samples were also analyzed with next-generation sequencing (Oncomine Dx Target Test Panel, Thermo Fisher Scientific). Results: An H-score of 150 or higher or the presence of at least 70% of tumor cells with an intensity of staining of 2+ or higher by the SP384 clone was the optimal cutoff value (both with 93% sensitivity and 100% specificity). The D4D6 clone showed similar results, with an H-score of at least 100 (91% sensitivity and 100% specificity). ROS1 expression in normal lung was more frequent with use of the SP384 clone (p < 0.0001). The ezrin gene (EZR)-ROS1 variant was associated with membranous staining and an isolated green signal FISH pattern (p = 0.001 and p = 0.017, respectively). Conclusions: The new SP384 ROS1 IHC clone showed excellent sensitivity without compromising specificity, so it is another excellent analytical option for the proposed testing algorithm.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Assessment of PD-L1 expression and tumour infiltrating lymphocytes in early-stage non-small cell lung carcinoma with artificial intelligence algorithms

  • Molero, Aida
  • Hernández, Susana
  • Alonso, Marta
  • Peressini, Melina
  • Curto, Daniel
  • López-Ríos Moreno, Fernando
  • Conde, Esther
Aims: To study programmed death ligand 1 (PD-L1) expression and tumour infiltrating lymphocytes (TILs) in patients with early-stage non-small cell lung carcinoma (NSCLC) with artificial intelligence (AI) algorithms. Methods: The study included samples from 50 early-stage NSCLCs. PD-L1 immunohistochemistry (IHC) stained slides (clone SP263) were scored manually and with two different AI tools (PathAI and Navify Digital Pathology) by three pathologists. TILs were digitally assessed on H&E and CD8 IHC stained sections with two different algorithms (PathAI and Navify Digital Pathology, respectively). The agreement between observers and methods for each biomarker was analysed. For PD-L1, the turn-around time (TAT) for manual versus AI-assisted scoring was recorded. Results: Agreement was higher in tumours with low PD-L1 expression regardless of the approach. Both AI-powered tools identified a significantly higher number of cases equal or above 1% PD-L1 tumour proportion score as compared with manual scoring (p=0.00015), a finding with potential therapeutic implications. Regarding TAT, there were significant differences between manual scoring and AI use (p value <0.0001 for all comparisons). The total TILs density with the PathAI algorithm and the total density of CD8+ cells with the Navify Digital Pathology software were significantly correlated (τ=0.49 (95% CI 0.37, 0.61), p value<0.0001). Conclusions: This preliminary study supports the use of AI algorithms for the scoring of PD-L1 and TILs in patients with NSCLC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma, the ROSING Study

  • Conde, Esther
  • Hernández, Susana
  • Martinez, Rebeca
  • Angulo, Bárbara
  • Castro, Javier de|||0000-0002-3622-6306
  • Collazo-Lorduy, Ana
  • Jiménez-Munarriz, Beatriz Carolina
  • Muriel, Alfonso|||0000-0002-4805-4011
  • Mate Sanz, Jose Luís|||0000-0002-4829-3426
  • Morán, Teresa
  • Aranda, Ignacio
  • Massuti, Bartomeu|||0000-0002-6247-4493
  • Rojo, Federico|||0000-0001-9989-0290
  • Dómine Gómez, Manuel|||0000-0003-1634-9832
  • Sansano, Irene|||0000-0003-0188-5210
  • Garcia, Felip
  • Felip, Enriqueta|||0000-0002-7620-0098
  • Mancheño, Nuria
  • Juan, Óscar|||0000-0002-7772-9030
  • Sanz, Julián
  • González Larriba, José Luis|||0000-0003-2631-0309
  • Atienza-Cuevas, Lidia
  • Arriola-Arellano, Esperanza
  • Abdulkader, Ihab
  • Garcia-Gonzalez, Jorge
  • Camacho, Carmen
  • Rodríguez-Abreu, Delvys|||0000-0003-0506-1366
  • Teixidó, Cristina|||0000-0002-7226-6567
  • Reguart, Noemi|||0000-0001-8190-499X
  • Gonzalez-Piñeiro, Ana
  • Lázaro, Martín|||0000-0002-0657-4713
  • Lozano, María Dolores
  • Gurpide, Alfonso
  • Gómez-Román, Javier
  • Lopez-Brea, M.
  • Pijuan, Lara|||0000-0002-9978-6933
  • Salido, Marta|||0000-0001-9988-5977
  • Arriola, Edurne|||0000-0001-8960-7519
  • Company, Amparo
  • Insa, Amelia|||0000-0002-3438-6170
  • Esteban Rodríguez, Isabel|||0000-0003-1576-7215
  • Saiz, Mónica
  • Azkona, Eider
  • Álvarez, Ramiro|||0000-0002-8053-7232
  • Artal, Ángel
  • Plaza, María Luz
  • Aguiar de Sousa, Diana|||0000-0002-6702-7924
  • Enguita, Ana Belén
  • Benito, Amparo
  • Paz-Ares, Luis|||0000-0002-3327-3246
  • Garrido, Pilar|||0000-0002-5899-6125
  • Lopez-Rios, Fernando
Introduction: The ROS1 gene rearrangement has become an important biomarker in NSCLC. The College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology testing guidelines support the use of ROS1 immunohistochemistry (IHC) as a screening test, followed by confirmation with fluorescence in situ hybridization (FISH) or a molecular test in all positive results. We have evaluated a novel anti-ROS1 IHC antibody (SP384) in a large multicenter series to obtain real-world data. Methods: A total of 43 ROS1 FISH-positive and 193 ROS1 FISH-negative NSCLC samples were studied. All specimens were screened by using two antibodies (clone D4D6 from Cell Signaling Technology and clone SP384 from Ventana Medical Systems), and the different interpretation criteria were compared with break-apart FISH (Vysis). FISH-positive samples were also analyzed with next-generation sequencing (Oncomine Dx Target Test Panel, Thermo Fisher Scientific). Results: An H-score of 150 or higher or the presence of at least 70% of tumor cells with an intensity of staining of 2+ or higher by the SP384 clone was the optimal cutoff value (both with 93% sensitivity and 100% specificity). The D4D6 clone showed similar results, with an H-score of at least 100 (91% sensitivity and 100% specificity). ROS1 expression in normal lung was more frequent with use of the SP384 clone (p < 0.0001). The ezrin gene (EZR)-ROS1 variant was associated with membranous staining and an isolated green signal FISH pattern (p = 0.001 and p = 0.017, respectively). Conclusions: The new SP384 ROS1 IHC clone showed excellent sensitivity without compromising specificity, so it is another excellent analytical option for the proposed testing algorithm.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours

  • Garrido, Pilar|||0000-0002-5899-6125
  • Hladun, Raquel|||0000-0002-3191-1750
  • De Álava, Enrique|||0000-0001-8400-046X
  • Alvarez, Rosa|||0000-0003-0935-8298
  • Bautista, Francisco Jose|||0000-0002-0421-8862
  • López-Ríos, F.
  • Colomer, Ramon|||0000-0002-6393-3444
  • Rojo, F.
The recent identification of rearrangements of neurotrophic tyrosine receptor kinase (NTRK) genes and the development of specific fusion protein inhibitors, such as larotrectinib and entrectinib, have revolutionised the diagnostic and clinical management of patients presenting with tumours with these alterations. Tumours that harbour NTRK fusions are found in both adults and children; and they are either rare tumours with common NTRK fusions that may be diagnostic, or more prevalent tumours with rare NTRK fusions. To assess currently available evidence on this matter, three key Spanish medical societies (the Spanish Society of Medical Oncology (SEOM), the Spanish Society of Pathological Anatomy (SEAP), and the Spanish Society of Paediatric Haematology and Oncology (SEHOP) have brought together a group of experts to develop a consensus document that includes guidelines on the diagnostic, clinical, and therapeutic aspects of NTRK -fusion tumours. This document also discusses the challenges related to the routine detection of these genetic alterations in a mostly public Health Care System.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years

  • Verdolini, Norma|||0000-0001-9488-2881
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Merchán-Naranjo, Jessica
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Salagre, Estela|||0000-0001-6352-5179
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Garriga, Marina|||0000-0001-7312-4969
  • Bioque, Miquel|||0000-0001-6887-7149
  • Vallespir, Catalina
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Vieta, Eduard|||0000-0002-0548-0053
  • Bernardo, Miquel|||0000-0001-8748-6717
The aim of the present study was to evaluate the contribution of family environment styles and psychiatric family history on functioning of patients presenting first-episode psychosis (FEP). Patients with FEP and healthy controls (HC) were assessed at baseline and after 2 years. The Functional Assessment Short Test (FAST) was used to assess functional outcome and the Family Environment Scale (FES) to evaluate family environment. Linear regressions evaluated the effect that family environment exerts on functioning at baseline and at 2-year follow-up, when FEP patients were diagnosed according to non-affective (NA-PSYCH) or affective psychoses (A-PSYCH). The influence of a positive parents' psychiatric history on functioning was evaluated through one-way between-groups analysis of covariance (ANCOVA) models, after controlling for family environmental styles. At baseline, FEP patients presented moderate functioning impairment, significantly worse than HC (28.65±16.17 versus 3.25±7.92; p<0.001, g = 1.91). At 2-year follow-up, the functioning of NA-PSYCH patients was significantly worse than in A-PSYCH (19.92±14.83 versus 12.46±14.86; p = 0.020, g = 0.50). No specific family environment style was associated with functioning in FEP patients and HC. On the contrary, a positive psychiatric father's history influenced functioning of FEP patients. After 2 years, worse functioning in NA-PSYCH patients was associated with lower rates of active-recreational and achievement orientated family environment and with higher rates of moral-religious emphasis and control. In A-PSYCH, worse functioning was associated with higher rates of conflict in the family. Both family environment and psychiatric history influence psychosocial functioning, with important implications for early interventions, that should involve both patients and caregivers.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prodromal phase, Differences in prodromal symptoms, risk factors and markers of vulnerability in first episode mania versus first episode psychosis with onset in late adolescence or adulthood

  • Verdolini, Norma|||0000-0001-9488-2881
  • Borràs, Roger|||0000-0002-8585-2522
  • Sparacino, Giulio
  • Garriga, Marina|||0000-0001-7312-4969
  • Sagué-Vilavella, Maria|||0000-0002-8037-7937
  • Madero, Santiago|||0000-0002-1123-4211
  • Palacios-Garrán, Roberto|||0000-0002-9047-3738
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Forte, Maria Florencia|||0000-0001-5930-5501
  • Salagre, Estela|||0000-0001-6352-5179
  • Aedo, Alberto|||0000-0003-0986-8773
  • Salgado-Pineda, Pilar|||0000-0001-7720-0885
  • Salvatierra, Irene Montoro
  • Sánchez Gistau, Vanessa|||0000-0002-8635-7144
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Carvalho, André F
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Undurraga, Juan|||0000-0001-6958-2369
  • Reinares, María|||0000-0001-8859-4453
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Vieta, Eduard|||0000-0002-0548-0053
  • Pacchiarotti, Isabella|||0000-0002-7822-0367
  • Amoretti, Silvia|||0000-0001-6017-2734
This study was aimed at identifying differences in the prodromal symptoms and their duration, risk factors and markers of vulnerability in patients presenting a first episode mania (FEM) or psychosis (FEP) with onset in late adolescence or adulthood in order to guide tailored treatment strategies. Patients with a FEM or FEP underwent a clinical assessment. Prodromes were evaluated with the Bipolar Prodrome Symptom Scale-Retrospective (BPSS-R). Chi-squared tests were conducted to assess specific prodromal symptoms, risk factors or markers of vulnerability between groups. Significant prodromal symptoms were entered in a stepwise forward logistic regression model. The probabilities of a gradual versus rapid onset pattern of the prodromes were computed with logistic regression models. The total sample included 108 patients (FEM = 72, FEP = 36). Social isolation was associated with the prodromal stage of a FEP whilst Increased energy or goal - directed activity with the prodrome to a FEM. Physically slowed down presented the most gradual onset whilst Increased energy presented the most rapid. The presence of obstetric complications and difficulties in writing and reading during childhood were risk factors for FEP. As for markers of vulnerability, impairment in premorbid adjustment was characteristic of FEP patients. No specific risk factor or marker of vulnerability was identified for FEM. Early characteristics differentiating FEP from FEM were identified. These findings might help shape early identification and preventive intervention programmes.